CBD has shown therapeutic potential in a wide range of psychiatric symptoms, including anxiety, which has been partly attributed to its interaction with the 5-HT1A receptor; this appears to happen in a dose-dependent fashion, suggesting that different dosages of CBD may have varying therapeutic outcomes [62].These findings emphasize the complexity of anxiety regulation and the potential for multi-target therapeutic strategies. The gene discussed is HTR1A; the disease is Anxiety.